KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement.
about
Prognostic Significance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: A Systematic Review and Meta-AnalysisClass III Receptor Tyrosine Kinases in Acute Leukemia - Biological Functions and Modern Laboratory AnalysisThe genomic landscape of testicular germ cell tumours: from susceptibility to treatment.Incidences and Prognostic Impact of c-KIT, WT1, CEBPA, and CBL Mutations, and Mutations Associated With Epigenetic Modification in Core Binding Factor Acute Myeloid Leukemia: A Multicenter Study in a Korean PopulationSignificance of KIT exon 17 mutation depends on mutant level rather than positivity in core-binding factor acute myeloid leukemiaMutation profiling of 19 candidate genes in acute myeloid leukemia suggests significance of DNMT3A mutationsThe use of molecular genetics to refine prognosis in acute myeloid leukemia.The spleen microenvironment influences disease transformation in a mouse model of KITD816V-dependent myeloproliferative neoplasm.D816 mutation of the KIT gene in core binding factor acute myeloid leukemia is associated with poorer prognosis than other KIT gene mutations.Recurrent Cytogenetic Abnormalities in Acute Myeloid Leukemia.C3aR1 gene overexpressed at initial stage of acute myeloid leukemia-M2 predicting short-term survival.Normal karyotype mosaicism in adult AML patients with adverse-risk and undefined karyotype: preliminary report of treatment outcomes after hematopoietic stem cell transplantation.Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation.Novel R634W c-kit mutation identified in familial mastocytosis.Acute myeloid leukemia
P2860
Q26771740-E71C1D37-F1BB-4A67-A471-BEB2DD841783Q26797245-9FFACA1C-B84D-4896-B65B-5F4E728E6E4DQ30249650-D6176C6B-7531-4DEB-8481-7FBB5E0C924FQ35332017-9A4B5EF9-DB65-42EE-AE2C-35901E87AE91Q36548080-76A3E86C-FB47-47A8-9C5D-E296D8B7AF01Q37688148-FC69E038-405F-4E72-9BE7-56CFE46B69AFQ38198569-EE0B6134-7E1D-4448-92E9-E57859FF439BQ42327796-8A03DC29-CE43-47B3-AA21-88F604B0A978Q48005752-62E0841F-4E71-46B0-9F25-4A16A6059277Q52817300-2DEC3498-15DB-41B2-9DA9-337AA7D7B86AQ53001186-28334484-D258-4D5A-85E1-33FC8D99A9FCQ53110056-37B7C5A4-EFEF-47A3-87FA-C747A5B3909CQ53265540-D656126B-868F-4388-B11A-1665C443E93AQ55071080-8553E821-7499-4FFB-B38F-1D4DD8B132D7Q58481761-6A0990E7-B5E5-448D-B708-0288F3D157E7
P2860
KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
KIT D816 mutation associates w ...... h RUNX1/RUNX1T1 rearrangement.
@en
type
label
KIT D816 mutation associates w ...... h RUNX1/RUNX1T1 rearrangement.
@en
prefLabel
KIT D816 mutation associates w ...... h RUNX1/RUNX1T1 rearrangement.
@en
P2093
P2860
P1433
P1476
KIT D816 mutation associates w ...... h RUNX1/RUNX1T1 rearrangement.
@en
P2093
Chang-Hun Park
Chul Won Jung
Dong Hwan Dennis Kim
Hee Kyung Ahn
Hee-Je Kim
Hee-Jin Kim
Hyeoung-Joon Kim
Jinny Park
Joon Ho Moon
P2860
P304
P356
10.1007/S00277-012-1580-5
P577
2012-09-28T00:00:00Z